missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ Recombinant Human CCSMST1 GST (N-Term) Protein

Codice prodotto. 18500073 Sfoglia Tutto Bio Techne Prodotti
Click to view available options
Quantità:
10 μg
25 μg
Dimensione della confezione:
10µg
25µg
Les retours ne sont pas autorisés pour ce produit. Consulta la politica di reso

Codice prodotto. 18500073

Marca: Novus Biologicals™ H00283951P0125ug

Effettua il per acquistare questo articolo Hai bisogno di un conto web ? Registrati oggi stesso!

This item is not returnable. View return policy

Recombinant Protein

This protein was produced in an in vitro wheat germ expression system that should preserve correct conformational folding that is necessary for biological function. While it is possible that this protein could display some level of activity, the functionality of this protein has not been explicitly measured or validated.
TRUSTED_SUSTAINABILITY

Specifications

Da utilizzare con (applicazione) Western Blot, ELISA, Protein Array, Immunoaffinity Purification
Formulazione 50 mM Tris-HCl, 10 mM reduced Glutathione, pH 8.0 in the elution buffer.
ID gene (immissione) 283951
Peso molecolare MolecularWeight-theroretical: 66.11 kDa
Quantità 25 μg
Requisiti di stoccaggio Store at -80°C. Avoid freeze/thaw cycles.
Alias gene C16orf91, CCSMST1, chromosome 16 open reading frame 91, gs103, MGC104723, protein CCSMST1
Simbolo del gene C16ORF91
Purity or Quality Grade >80% by SDS-PAGE and Coomassie blue staining
Proteine CCSMST1
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.